iPS Cell Line Derived from Multipotent Stem Cell

 

CET.IPS MULT-500 was created by reprogramming cultured human cord blood-derived multipotent stem cell derived from discarded cord blood of a normal newborn delivery. Tissue was collected by informed consent in accordance with approved Institutional Review Board procedures. The pluripotency of this iPS cell line was validated as fully pluripotent based on colony morphology, alkaline phosphatase staining, antibody testing of Nanog, Oct 4, SSEA-3 and TRA-160 expression and teratoma formation.